Products

DermalRx® SRC-R (R10099) is a yeast-derived oligopeptide that promotes skin renewal by stimulating natural exfoliation via gentle and selective desquamation. Clinical testing demonstrates that DermalRx® SRC-R enhances exfoliation to reduce skin roughness and improve the appearance of wrinkles in four weeks. DermalRx® SRC-R gently loosens coarse keratinized cells at the surface, delivering results for applications in anti-aging, anti-wrinkle, anti-blemish, skin brightening, and exfoliation products. DermalRx® SRC-R is clinically demonstrated to restore skin texture and radiance with documented improvements in the appearance of hyperpigmentation, wrinkles, and other signs of aging. DermalRx® SRC-R is a selective exfoliant for safe, effective skin renewal.

DermalRx® SRC (R10001) is a yeast-derived oligopeptide that promotes skin renewal by stimulating natural exfoliation via gentle and selective desquamation. Clinical testing demonstrates that DermalRx® SRC enhances exfoliation to reduce skin roughness and improve the appearance of wrinkles in four weeks. DermalRx® SRC gently loosens coarse keratinized cells at the surface, delivering results for applications in anti-aging, anti-wrinkle, anti-blemish, skin brightening, and exfoliation products. DermalRx® SRC is clinically demonstrated to restore skin texture and radiance with documented improvements in the appearance of hyperpigmentation, wrinkles, and other signs of aging. DermalRx® SRC is a selective exfoliant for safe, effective skin renewal.

Cogesome® SA (R10126) is a novel and proprietary liposome formulation that encapsulates salicylic acid (SA) for improved long-term stability and pH to near physiological levels, optimal miscibility in aqueous and glycolic systems, and superior penetration into the skin. Cogesome® SA is well suited for formulas to address blemished skin, including spot treatments, cleansing, and clarifying products, and overnight resurfacing treatments, as well as other skin and hair formulas.Cogesome® SA supports superior skin penetration properties without the irritation associated with traditional salicylic acid. Cogesome® SA is stable and soluble in water for easy formulation in aqueous-based formulation systems. Cogesome® SA is a completely liposome-encapsulated salicylic acid with high miscibility and a pH of 6-7.4, close to physiological pH. As such, the incorporation of salicylic acid by Cogesome® SA does not significantly impact the pH of the final formulation. Cogesome® SA is a high-technology solution for blemish-prone skin.

Grandiciin® (R10124) is an Epimedium extract featuring a beneficial mix of prenylated flavonoids for addressing blemished skin. Applications for Grandiciin® include microbiome-balancing products, anti-blemish and spot treatments, anti-sebum and oil-reducing hair and skin care, and soothing and calming body care regimens for damaged skin. Grandiciin® improves skin health and wellness through microbiome-rebalancing activity, reducing the problematic Cutibacterium acnes (formerly Propionibacterium acnes) biofilms that contribute to inflammation, redness, and blemish formation. Grandiciin® is clinically shown to diminish C. acnes burden on the skin while also reducing sebum (oil) production and signs of inflammation and redness and improving the appearance of blemishes in four weeks. Grandiciin® addresses inflammatory, proteolytic, and oxidative stress to provide an extra layer of protection against tissue damage and scarring in severely blemished skin.